Vilanto-UF DPI Capsule is indicated:
• As a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist.
• For the maintenance treatment of asthma in patients aged 18 years and older